Sintetica

Privately held: no public share price · Switzerland

Assets

(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Approved
Voltage-gated sodium channels (Nav) on sensory nerve membranesSmall molecule
Ocular Anesthesia
Ocular Surface Anesthesia

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Regulatory and conference events

(1)

Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.

Recent

20 August 2026Topline resultchloroprocaineIHEEZO contralateral-eye study vs proparacaine in intravitreal injections

Financial reports

No financial reports recorded.